Related references
Note: Only part of the references are listed.In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree
Mee Rie Sheen et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2019)
Genetically Programmable Self-Regenerating Bacterial Hydrogels
Anna M. Duraj-Thatte et al.
ADVANCED MATERIALS (2019)
Tumor Seeding During Colonoscopy as a Possible Cause for Metachronous Colorectal Cancer
Yara Backes et al.
GASTROENTEROLOGY (2019)
Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
Chanyoung Song et al.
NATURE COMMUNICATIONS (2019)
The prognostic role of circulating tumor cells in colorectal cancer
Lahiri Kanth Nanduri et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen et al.
NATURE NANOTECHNOLOGY (2019)
Minimally Invasive Colorectal Surgery - Present and Future Trends
Oana Stanciulea et al.
CHIRURGIA (2019)
Implantable Synthetic Immune Niche for Spatiotemporal Modulation of Tumor-Derived Immunosuppression and Systemic Antitumor Immunity: Postoperative Immunotherapy
Hathaichanok Phuengkham et al.
ADVANCED MATERIALS (2018)
Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
Chun Gwon Park et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Eradication of spontaneous malignancy by local immunotherapy
Idit Sagiv-Barfi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
Chao Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
Wantong Song et al.
NATURE COMMUNICATIONS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma
Jason R. Baird et al.
CANCER RESEARCH (2018)
Degradation-Regulatable Architectured Implantable Macroporous Scaffold for the Spatiotemporal Modulation of Immunosuppressive Microenvironment and Enhanced Combination Cancer Immunotherapy
Long Ren et al.
ADVANCED FUNCTIONAL MATERIALS (2018)
The importance of correctly timing cancer immunotherapy
Elham Beyranvand Nejad et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Determinants of metastatic competency in colorectal cancer
Daniele V. F. Tauriello et al.
MOLECULAR ONCOLOGY (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook
Chao Wang et al.
ADVANCED MATERIALS (2017)
A novel injectable tissue adhesive based on oxidized dextran and chitosan
Biji Balakrishnan et al.
ACTA BIOMATERIALIA (2017)
Systemic Immunity Is Required for Effective Cancer Immunotherapy
Matthew H. Spitzer et al.
CELL (2017)
Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody
Chao Wang et al.
ADVANCED MATERIALS (2016)
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
Lars Hofmann et al.
EUROPEAN JOURNAL OF CANCER (2016)
Metastasis as an evolutionary process
Samra Turajlic et al.
SCIENCE (2016)
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
Qian Chen et al.
NATURE COMMUNICATIONS (2016)
Biopolymer implants enhance the efficacy of adoptive T-cell therapy
Sirkka B. Stephan et al.
NATURE BIOTECHNOLOGY (2015)
The evolution of cancer surgery and future perspectives
Lynda Wyld et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Low cytotoxic tissue adhesive based on oxidized dextran and epsilon-poly-L-lysine
Suong-Hyu Hyon et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2014)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Antibodies Targeting Human OX40 Expand Effector T Cells and Block Inducible and Natural Regulatory T Cell Function
Kui S. Voo et al.
JOURNAL OF IMMUNOLOGY (2013)
Polarization of Tumor-Associated Macrophages: A Novel Strategy for Vascular Normalization and Antitumor Immunity
Yuhui Huang et al.
CANCER CELL (2011)
Immunotherapeutic modulation of the suppressive liver and tumor microenvironments
Tim Chan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Significance of M2-Polarized Tumor-Associated Macrophage in Pancreatic Cancer
Hiroshi Kurahara et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
Kathy S. Albain et al.
LANCET (2009)
Infection-mimicking materials to program dendritic cells in situ
Omar A. Ali et al.
NATURE MATERIALS (2009)
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy
Evelien L. J. M. Smits et al.
ONCOLOGIST (2008)
Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity
Arthur M. Krieg et al.
IMMUNOLOGICAL REVIEWS (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites
Yutaka Yonemura et al.
CANCER SCIENCE (2007)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses
K Loré et al.
JOURNAL OF IMMUNOLOGY (2003)
Share Paper
